UOC
ASXC

UBS O'Connor’s Asensus Surgical, Inc. ASXC Stock Holding History

UBS O'Connor’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-42,261
Closed -$390K – 461
2017
Q2 		$390K Buy
+42,261
New +$402K 0.01% 345
2015
Q3 		– Sell
-20,197
Closed -$788K – 765
2015
Q2 		$788K Buy
+20,197
New +$930K 0.01% 460

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS O'Connor's ASXC Position: Q3 2017 in Review

UBS O'Connor sold out of Asensus Surgical, Inc. (ASXC) in Q3 2017, closing a stake of 42,261 shares — an estimated $390K sold.

UBS O'Connor first reported a position in ASXC in Q2 2015 and held it in 2 quarters. The position peaked at $788K in Q2 2015. 62 funds tracked by Wall St. Rank hold ASXC as of Q3 2017.

  • UBS O'Connor reported no remaining Asensus Surgical, Inc. position as of Q3 2017 after selling out during the quarter.
  • UBS O'Connor sold 42,261 Asensus Surgical, Inc. shares in Q3 2017, an estimated $390K.
  • UBS O'Connor first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 2 quarters.
  • UBS O'Connor's Asensus Surgical, Inc. position peaked at $788K in Q2 2015.
  • 62 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2017.

Based on UBS O'Connor's 13F filing for Q3 2017, filed 14 Nov 2017.